Table 1. Age-specific results of primary HPV screening with the HC2 test and cytology triage test among eligible women who attended HPV screening trial in years 2003–2005.

	HPV screening					Cytology triagea
	Total	Negative		Positive		Normal		ASC-USb		LSIL+c
Age group (y)	n	n	%	n	%	n	% of HC2+	n	% of HC2+	n	% of HC2+
25	1 724	1 307	75.8	417	24.2	258	61.7	97	23.2	62	14.8
30	3 724	3 174	85.2	550	14.8	321	58.3	132	24.0	97	17.6
35	3 900	3 531	90.5	369	9.5	194	52.3	99	26.7	76	20.5
40	4 649	4 347	93.5	302	6.5	167	55.1	74	24.4	61	20.1
45	4 335	4 112	94.9	223	5.1	145	64.7	52	23.2	26	11.6
50	4 575	4 342	94.9	233	5.1	154	65.8	58	24.8	21	9.0
55	4 885	4 629	94.8	256	5.2	182	70.8	46	17.9	28	10.9
60	3 988	3 798	95.2	190	4.8	139	72.0	28	14.5	23	11.9
65	1 215	1 181	97.2	34	2.8	22	64.7	8	23.5	4	11.8
Total	32 995	30 421	92.3	2574	7.8	1582	61.5	594	23.1	398	15.5

Abbreviations: HC2=Hybrid Capture 2; HC2+=positive result in the HC2 test.

^aCytology triage missing or smear unsatisfactory for seven women who were included and cytology result was assumed to be normal.

^bPapanicolaou class II.

^cPapanicolaou class III-V, small proportion of II.